[
    [
        {
            "time": "",
            "original_text": "大参林医药集团股份有限公司监事会关于2020年限制性股票激励计划预留股票激励对象名单审核意见及公示情况的说明",
            "features": {
                "keywords": [
                    "大参林",
                    "医药集团",
                    "监事会",
                    "限制性股票",
                    "激励计划",
                    "预留股票",
                    "激励对象",
                    "审核意见",
                    "公示情况"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "大参林医药集团股份有限公司监事会关于2020年限制性股票激励计划预留股票激励对象名单审核意见及公示情况的说明",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 4,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        }
    ]
]